staurosporine has been researched along with ponatinib in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aziz, AK; Abouzid, KAM; Dokla, EME; McPhillie, MJ; Milik, SN; Minucci, S | 1 |
| Blatt, K; Gleixner, KV; Hadzijusufovic, E; Peter, B; Radia, D; Reiter, A; Suppan, V; Valent, P | 1 |
| Andreeff, M; Cortes, J; Kantarjian, H; Pemmaraju, N; Ravandi, F | 1 |
| Ebihara, Y; Hanada, S; Imai, K; Konishi, C; Matsuzaka, E; Mochizuki, S; Nakauchi, H; Otsu, M; Takagi, H; Tsuji, K; Yamamoto, S | 1 |
| Dixit, SM; Kulju, KD; Polasky, DA; Ruotolo, BT; Vallejo, DD | 1 |
| Albors Ferreiro, M; Alonso Vence, N; Antelo Rodríguez, B; Bao Pérez, L; Bello López, JL; Cerchione, C; Cid López, M; Díaz Arias, JÁ; Ferreiro Ferro, R; González Pérez, MS; Martinelli, G; Mosquera Orgueira, A; Mosquera Torre, A; Peleteiro Raíndo, A; Pérez Encinas, MM | 1 |
2 review(s) available for staurosporine and ponatinib
| Article | Year |
|---|---|
Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Humans; Imidazoles; Leukemia, Myeloid, Acute; Niacinamide; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Pyridazines; Sorafenib; Staurosporine | 2014 |
FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectives.
Topics: Aniline Compounds; Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Carbazoles; Drug Resistance, Multiple; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Forecasting; Furans; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mutation; Phenylurea Compounds; Piperidines; Point Mutation; Protein Kinase Inhibitors; Pyrazines; Pyridazines; Recurrence; Sorafenib; Staurosporine | 2020 |
4 other study(ies) available for staurosporine and ponatinib
| Article | Year |
|---|---|
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; fms-Like Tyrosine Kinase 3; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Receptor, trkA; Structure-Activity Relationship | 2022 |
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V.
Topics: Adult; Aged; Antineoplastic Agents; Cell Line, Tumor; Drug Synergism; Female; Growth Inhibitors; Humans; Imidazoles; Male; Mastocytosis, Systemic; Middle Aged; Proto-Oncogene Proteins c-kit; Pyridazines; Staurosporine | 2013 |
Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
Topics: Adolescent; Benzimidazoles; Cells, Cultured; Drug Evaluation, Preclinical; Hematopoiesis; Humans; Imatinib Mesylate; Imidazoles; Induced Pluripotent Stem Cells; Male; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Staurosporine; Translocation, Genetic | 2015 |
An Algorithm for Building Multi-State Classifiers Based on Collision-Induced Unfolding Data.
Topics: Algorithms; Anilides; Dasatinib; Escherichia coli; High-Throughput Screening Assays; Humans; Imidazoles; Immunoglobulin Isotypes; Models, Molecular; Multiple Myeloma; Protein Kinase Inhibitors; Protein Structure, Secondary; Pyridazines; Quinolines; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; src-Family Kinases; Static Electricity; Staurosporine | 2019 |